FindTrial
Sign In

The cost-effectiveness study of population-based screening of hepatitis C virus (HCV) infection: Evidence for effective control of HCV in Korea

The nationawide prevalence of hepatitis C, B and A in 2015

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002077
Enrollment
15000
Registered
2016-09-27
Start date
2016-08-08
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Korean population age of 40-66 years

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
QALY (quality-adjusted life year) and ICER(incremental cost-effectiveness ratio)—

Secondary

MeasureTime frame
anti-HCV prevalence, anti-HAV & anti-HBs prevalence if data are available—

Countries

Korea, Republic of

Contacts

Public ContactSook-Hyang Jeong

Seoul National University Bundang Hospital

jsh@snubh.org+82-31-787-7029

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026